Come True Biomedical Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was TWD 8.328 million compared to TWD 11.615 million a year ago. Operating loss was TWD 6.058 million compared to TWD 5.250 million a year ago. Net loss was TWD 5.389 million compared to TWD 3.111 million a year ago. Basic loss per share from continuing operations was TWD 0.17 compared to TWD 0.08 a year ago. Basic loss per share was TWD 0.17 compared to TWD 0.1 a year ago. For the nine months, total revenue was TWD 29.807 million compared to TWD 23.560 million a year ago. Operating loss was TWD 12.901 million compared to TWD 22.478 million a year ago. Net loss was TWD 11.129 million compared to TWD 22.866 million a year ago. Basic loss per share from continuing operations was TWD 0.35 compared to TWD 0.48 a year ago. Basic loss per share was TWD 0.35 compared to TWD 0.72 a year ago.